Immuno-oncology Therapy Market by Therapy Type (Monoclonal Antibodies, Immune Checkpoint Inhibitors (PD-1/PD-L1 and CTLA-4), Immune System Modulators, and Cancer Vaccines) and by Therapeutic Areas, for Hospitals, Clinics, ASC’s and Cancer Research Institutes: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Global immuno-oncology therapy market is expected to reach USD 97.34 billion by end of 2022, growing at a CAGR of 14.6% between 2017 and 2022.

Choose License

17-Jan-2018 | Number of pages: 110 | Report Code: ZMR-2534 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the immuno-oncology therapy market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the immuno-oncology therapy market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the immuno-oncology therapy market on a global level.

In order to give the users of this report a comprehensive view of the immuno-oncology therapy market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein therapy type segment, therapeutic area segment, and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

The study provides a decisive view on the immuno-oncology therapy market by segmenting the market based on therapy type, therapeutic area, end-user, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2016 to 2022. Based on therapy type the market is segmented into monoclonal antibodies, immune checkpoint inhibitors (PD1/ PDL1 and CTLA-4), immune system modulators, cancer vaccines and others. Based on the therapeutic area the market is segmented into lung cancer, colorectal cancer, breast cancer, prostate cancer, melanoma, blood cancer and other cancers. Key end-users covered under this study include hospitals, clinics, ASC’s and cancer research institutes. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East & Africa with its further bifurcation into major countries including the U.S., Canada, Rest of North America, U.K., Germany, France, Italy, Spain, Russia, Rest of Europe, China, Japan, India, Australia, Rest of Asia Pacific, Brazil, Mexico, Argentina, Rest of Latin America, Saudi Arabia, UAE, Qatar, South Africa and Rest of Middle East and Africa. This segmentation includes demand for immuno-oncology therapy market based on individual therapy type, therapeutic area and end-users in all the regions and countries.

The report also includes detailed profiles of end players such as Amgen, Inc., AstraZeneca Plc., Bristol-Myers Squibb Company, Eli Lilly and Company, F.Hoffmann-La Roche Ltd., GlaxoSmithKline Plc., Janssen Biotech, Merck and Co., Novartis AG, Pfizer, Inc., Sanofi, Spectrum Pharmaceuticals, Inc. and Takeda Pharmaceuticals.

This report segments the global immuno-oncology therapy market as follows:

Global Immuno-oncology Therapy Market: Therapy Type Segment Analysis

  • Monoclonal Antibodies
  • Immune Checkpoint Inhibitors
    • PD-1/ PD-L1
    • CTLA-4
  • Immune System Modulators
  • Cancer Vaccines
  • Others

Global Immuno-oncology Therapy Market: Therapeutic Area Segment Analysis

  • Lung Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Prostate Cancer
  • Melanoma
  • Blood Cancer
  • Others Cancers

Global Immuno-oncology Therapy Market: End-user Segment Analysis

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers (ASC’s)
  • Cancer Research Institutes

Global Immuno-oncology Therapy Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Allergy Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2634 | Report Format:

Global Allergy Treatment Market: Overview An allergy is an immune systems sharp sensitivity. An allergy happens when a foreign material that is risk-free in nature has a reaction to the immune system. These foreign materials are dubbed as allergens. Some of the allergens that impact the immune s...Read More

Contract Research Organization Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2628 | Report Format:

Global Contract Research Organization Market: Overview CRO (contract research organization) is as an organization providing services and assistance usually to the biotechnology and pharmaceutical industries in various forms such as drug tests, data research, post-development marketing, clinical ...Read More

Migraine Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2605 | Report Format:

Global Migraine Drugs Market: Overview About 1214% of people around the world suffer from a Migraine; it is a type of a headache. According to regional and international rules, migraine is classified by the nature of the attack and its frequency into a chronic migraine and episodic migraine. Pro...Read More

Cardiovascular Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2602 | Report Format:

Global Cardiovascular Drugs Market: Overview Cardiovascular diseases are popularly known as heart diseases. These diseases are associated with circulatory system and heart. To list a few common cardiovascular diseasesrheumatic heart disease, hypertensive heart disease, inflammatory heart disease...Read More

Sports Medicine Market by Product Type (Body Reconstruction Products, Body Support & Recovery and Accessories) and by Application like Shoulder Injuries, Ankle & Foot Injuries, Elbow & Wrist Injuries, Back & Spine Injuries, Hip & Groin Injuries, Knee Injuries and Other Injuries - Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2022

Feb-2018 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2598 | Report Format:

The report covers forecast and analysis for the Sports Medicine market on a global and regional level. The study provides historical data from 2014 along with a forecast from 2018 to 2022 based on revenue (USD Million). The study includes drivers and restraints for the Sports Medicine market along...Read More

Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.

Quick Inquiry